deListed Australia
 
SEARCH LISTED OR DELISTED COMPANY
Any AUS or NZ company

Browse Australian delisted companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse terminated Australian managed funds

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
SEARCH PRIVATE COMPANY
SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

APOLLO CONSOLIDATED LIMITED (ASX.AOP)

ASX Announcements (courtesy of ASX)

2009201020112012201320142015201620172018201920202021

ASX, Legal & CGT Status

SHARE PRICES

(updated at weekends)
Former (or subsequent) names
Shareholder links
Our website ranking of AOP: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:
Computershare Perth
Level 17, 221 St Georges Terrace, Perth WA 6000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details
ISIN: AU000000AOP2
Address: 1202 Hay Street West Perth, WA 6005
Tel:  +61 (0) 8 6319 1900 Fax: +61 (0) 8 6314 1557

Date first listed: 29/06/2005

Sector: Materials
Industry Group: XMJ
Activities: The Company develops and markets a range of over the counter (OTC) skin care products

many shareholders in this company have unclaimed money due to them - deListed provides a tracing service for a small administration fee that identifies where people can find unclaimed monies arising from compulsory acquisitions and also from dividend distributions, super contributions, inoperative bank, building society or credit union accounts, bequests and other sources - please click here for access to our Lost shares, Lost money service

22/03/2023

delisted following compulsory acquisition under Listing Rule 17.14

17/12/2021

we understand Ramelius Resources Limited was successful with an offer of $0.34 cash and 0.1778 Ramelius shares for each Apollo share

17/12/2021

The securities of Apollo Consolidated Limited will be suspended from quotation at the close of trading today, Monday, 13 December 2021, in accordance with Listing Rule 17.4, following despatch of the compulsory acquisition notices by Ramelius Resources Limited.

13/12/2021

Apollo Consolidated Limited (the "Company") will be reinstated to official quotation as from the commencement of trading on Wednesday, 11 April 2012, following the Company" compliance with listing rule 11.1.3 and chapters 1 and 2 of the ASX listing rules

10/04/2012

releases Half Year Accounts

14/03/2012

lodges third Supplementary Prospectus

01/03/2012

lodges second Supplementary Prospectus dated 27 February 2012

27/02/2012

issues supplementary prospectus

21/02/2012

releases a prospectus inviting applications for 10,000,000 Shares at an issue price of $0.20 per Share to raise $2,000,000. The Company may accept oversubscriptions of up to a further 2,500,000 Shares at an issue price of $0.20 per Share to raise up to a further $500,000

08/02/2012

reports that during the December quarter, the company moved toward finalisation of the Aspire Cote d'Ivoire transaction as announced to ASX on September 6, 2011 At a general meeting held on December 23, 2011, shareholders voted overwhelmingly to approve the Transaction and to change the nature of the activities of the company to focus on gold exploration at its Ivorian projects and on the advanced Rebecca Project.

01/02/2012

releases a shareholder presentation

24/01/2012

company advises that it has appointed BBY Limited (BBY) as sponsoring broker to the Company's offer of 10,000,000 new fully paid ordinary shares at an issue price of $0.20 per share (Offer) to raise up to $2,000,000 (before costs). Under the terms of the Offer, which is not underwritten, the Company may also accept oversubscriptions of up to 2,500,000 further shares at $0.20 per share to raise an additional $500,000

24/01/2012

we understand that on or about this date the company consolidated its shares 1 for 30

31/12/2011

all resolutions considered at the General Meeting were passed on a show of hands - trading in the Company's securities will remain suspended pending compliance with Chapters 1 & 2 of the Listing Rules, including lodgement of a prospectus (Prospectus) and completion of the placement of shares approved by the meeting (Placement). Preparation of the Prospectus is well advanced and it is now expected that this will be lodged in mid-January 2012

23/12/2011

the securities of Apollo Consolidated Limited (the "Company") will be suspended from official quotation from the commencement of trading on Friday 23 December 2011, pending the outcome of a resolution at the Company's general meeting to approve a change in the nature of the Company's activities. The Company's securities will remain suspended pending compliance with Chapters 1 and 2 of the Listing Rules

22/12/2011

Apollo Consolidated reported negative cash flow of $93,000 for quarter ended 30 September 2011. Operating cash flow for the period was $(83,000). Investing cash flow was $(10,000). Financing cash flow was nil. Cash in hand at the end of the quarter was $1.4m

17/10/2011

the securities of Apollo Consolidated Limited (the "Company") will be suspended from quotation immediately, following the announcement of the Company's proposed change of activities and its recompliance with chapters 1 and 2 of the Listing Rules

06/09/2011

the suspension of trading in the securities of Apollo Consolidated Limited (the "Company") will be lifted before the commencement of trading on Wednesday, 7 September 2011, following the announcement by the Company of its proposed change of activities and its re-compliance with chapters 1 and 2 of the Listing Rules

06/09/2011

securities reinstated to quotation

07/10/2009

releases Half Year Accounts to 31 December 2008

06/10/2009

offers under the Company's prospectus dated 4 September 2009 ("Prospectus") have closed, oversubscribed. Shares have now been allotted and Apollo's directors resolved to accept the maximum number of oversubscriptions permitted under the Prospectus General Offer, being an additional 120,000,000 shares

05/10/2009

the deed of company arrangement has been effectuated and control of the company reverts to its directors

02/10/2009

issues a supplementary prospectus

30/09/2009

name changed from Apollo Life Sciences Limited

09/09/2009
View ASX Announcements (courtesy of ASX)

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates
Post your comments here
Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    loading Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNATURENUMBERPRICEAMOUNT
    18/04/2018Anthony James75,000$0.260$19,500
    19/03/2018Stephen West300,000$0.250$75,000
    05/07/2012Nick CastledenOn market200,000$0.100$20,000

    Click here for the last 20 transactions all companies

    Directors & Executives (current)
    NAMETITLEDATE OF APPT
    Roger SteinepreisChairman04/08/2009
    Nick CastledenManaging Director, CEO04/08/2009
    Tim MannersDirector22/11/2021
    Bob VassieDirector22/11/2021
    Mark ZeptnerDirector22/11/2021
    Alex NeulingCompany Secretary
    Richard JonesCompany Secretary

    Date of first appointment, title may have changed.

    SPECIAL NOTE: During May 2024 we are working to remove duplications in the Company Secretary role.

    Directors & Executives (former)
    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Anthony JamesNon Exec Director18/04/201822/11/2021
    Robert GherghettaNon Exec Director16/04/201222/11/2021
    George VentourasNon Exec Director04/08/200902/10/2018
    Stephen WestNon Exec Director16/04/201218/04/2018
    John PriestCEO12/09/200204/08/2009
    Paul MurnaneNon Exec Director22/04/200404/08/2009
    Antony BastenNon Exec Director21/04/200404/08/2009
    Jane CraigCOO20/06/200301/05/2008
    Bill MossNon Exec Director07/03/200603/10/2007
    Greg Russell-JonesScientific Director26/05/200619/07/2007
    Garry KaanCFO12/12/200625/05/2007
    Alan WattsNon Exec Director21/04/200421/07/2006

    Date of first appointment, title may have changed.